Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2010 (2010), Article ID 640797, 14 pages
http://dx.doi.org/10.1155/2010/640797
Research Article

Rosuvastatin Counteracts Vessel Arterialisation and Sinusoid Capillarisation, Reduces Tumour Growth, and Prolongs Survival in Murine Hepatocellular Carcinoma

1Institut des Vaisseaux et du Sang, Hôpitlal Lariboisière, 2 Rue Ambroise Paré, 75010 Paris, France
2“Angiogenèse et Recherche Translationnelle” INSERM U 965 “Equipe labellisée Ligue 2009”, HÔpital Lariboisière, 2 Rue Ambroise Paré, 75010 Paris, France
3Université Paris 7 Denis Diderot, 10 Avenue de Verdun, 75010 Paris, France
4Laboratoire M.E.R.C.I, Université de Rouen, 22 Boulevard Gambetta, 76183 Rouen Cedx, France
5HÔpital Lariboisière, 2 Rue Ambroise Paré, 75010 Paris, France
6Paris Cardiovascular Research Center, INSERM U970, HÔpital Européen Georges Pompidou, 20 Rue Leblanc, 75015 Paris, France
7HÔpital Européen Georges Pompidou, 20 Rue Leblanc, 75015 Paris, France
8Université Descartes-Paris 5, 12 Rue de l’École de Médecine, 75006 Paris, France

Received 29 September 2010; Accepted 28 December 2010

Academic Editor: Fabio Marra

Copyright © 2010 Annemilaï Tijeras-Raballand et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Fernández, D. Semela, J. Bruix, I. Colle, M. Pinzani, and J. Bosch, “Angiogenesis in liver disease,” Journal of Hepatology, vol. 50, no. 3, pp. 604–620, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Ribatti, A. Vacca, B. Nico, D. Sansonno, and F. Dammacco, “Angiogenesis and anti-angiogenesis in hepatocellular carcinoma,” Cancer Treatment Reviews, vol. 32, no. 6, pp. 437–444, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. J. M. Llovet, S. Ricci, V. Mazzaferro et al., “Sorafenib in advanced hepatocellular carcinoma,” New England Journal of Medicine, vol. 359, no. 4, pp. 378–390, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Montero, A. Morales, L. Llacuna et al., “Mitochondrial cholesterol contributes to chemotherapy resistance in hepatocellular carcinoma,” Cancer Research, vol. 68, no. 13, pp. 5246–5256, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Jakobisiak and J. Golab, “Statins can modulate effectiveness of antitumor therapeutic modalities,” Medicinal Research Reviews, vol. 30, no. 1, pp. 102–135, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Kuoppala, A. Lamminpää, and E. Pukkala, “Statins and cancer: a systematic review and meta-analysis,” European Journal of Cancer, vol. 44, no. 15, pp. 2122–2132, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. H. B. El-Serag, M. L. Johnson, C. Hachem, and R. O. Morgana, “Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes,” Gastroenterology, vol. 136, no. 5, pp. 1601–1608, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. C. K. Argo, P. Loria, S. H. Caldwell, and A. Lonardo, “Statins in liver disease: a molehill, an iceberg, or neither?” Hepatology, vol. 48, no. 2, pp. 662–669, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Kawata, E. Yamasaki, T. Nagase et al., “Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial,” British Journal of Cancer, vol. 84, no. 7, pp. 886–891, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Graf, C. Jüngst, G. Straub et al., “Chemoembolization combined with pravastatin improves survival in patients with hepatocellular carcinoma,” Digestion, vol. 78, no. 1, pp. 34–38, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Dulak and A. Józkowicz, “Anti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapy,” Current Cancer Drug Targets, vol. 5, no. 8, pp. 579–594, 2005. View at Google Scholar · View at Scopus
  12. C. Urbich, E. Dernbach, A. M. Zeiher, and S. Dimmeler, “Double-edged role of statins in angiogenesis signaling,” Circulation Research, vol. 90, no. 6, pp. 737–744, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Weis, C. Heeschen, A. J. Glassford, and J. P. Cooke, “Statins have biphasic effects on angiogenesis,” Circulation, vol. 105, no. 6, pp. 739–745, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. X. Y. Zhu, E. Daghini, A. R. Chade et al., “Disparate effects of simvastatin on angiogenesis during hypoxia and inflammation,” Life Sciences, vol. 83, no. 23-24, pp. 801–809, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. M. F. Demierre, P. D. R. Higgins, S. B. Gruber, E. Hawk, and S. M. Lippman, “Statins and cancer prevention,” Nature Reviews Cancer, vol. 5, no. 12, pp. 930–942, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. M. R. Graaf, D. J. Richel, C. J. F. van Noorden, and H. J. Guchelaar, “Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer,” Cancer Treatment Reviews, vol. 30, no. 7, pp. 609–641, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Vincent, C. Soria, F. Mirshahi et al., “Cerivastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, inhibits endothelial cell proliferation induced by angiogenic factors in vitro and angiogenesis in in vivo models,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 4, pp. 623–629, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Bergers and L. E. Benjamin, “Tumorigenesis and the angiogenic switch,” Nature Reviews Cancer, vol. 3, no. 6, pp. 401–410, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. R. K. Jain, “Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy,” Science, vol. 307, no. 5706, pp. 58–62, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. D. M. McDonald and P. Baluk, “Imaging of angiogenesis in inflamed airways and tumors: newly formed blood vessels are not alike and may be wildly abnormal: Parker B. Francis lecture,” Chest, vol. 128, no. 6, pp. 602S–108S, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. BO. Xu, U. Broome, M. Uzunel et al., “Capillarization of hepatic sinusoid by liver endothelial cell-reactive autoantibodies in patients with cirrhosis and chronic hepatitis,” American Journal of Pathology, vol. 163, no. 4, pp. 1275–1289, 2003. View at Google Scholar · View at Scopus
  22. E. Dupuy, P. Hainaud, A. Villemain et al., “Tumoral angiogenesis and tissue factor expression during hepatocellular carcinoma progression in a transgenic mouse model,” Journal of Hepatology, vol. 38, no. 6, pp. 793–802, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Hainaud, J. O. Contrerès, A. Villemain et al., “The role of the vascular endothelial growth factor-Delta-like 4 ligand/Notch4-Ephrin B2 cascade in tumor vessel remodeling and endothelial cell functions,” Cancer Research, vol. 66, no. 17, pp. 8501–8510, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Bonnin, A. Villemain, F. Vincent et al., “Ultrasonic assessment of hepatic blood flow as a marker of mouse hepatocarcinoma,” Ultrasound in Medicine and Biology, vol. 33, no. 4, pp. 561–570, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Van de Veire, I. Stalmans, F. Heindryckx et al., “Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease,” Cell, vol. 141, no. 1, pp. 178–190, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Rossant and M. Hirashima, “Vascular development and patterning: making the right choices,” Current Opinion in Genetics and Development, vol. 13, no. 4, pp. 408–412, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Kume, “Novel insights into the differential functions of Notch ligands in vascular formation,” Journal of Angiogenesis Research, vol. 1, p. 8, 2009. View at Google Scholar
  28. L. Riccalton-Banks, R. Bhandari, J. Fry, and K. M. Shakesheff, “A simple method for the simultaneous isolation of stellate cells and hepatocytes from rat liver tissue,” Molecular and Cellular Biochemistry, vol. 248, no. 1-2, pp. 97–102, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Fukui, S. Tamura, A. Wada et al., “Expression and prognostic role of RhoA GTPases in hepatocellular carcinoma,” Journal of Cancer Research and Clinical Oncology, vol. 132, no. 10, pp. 627–633, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Sterpetti, L. Marucci, C. Candelaresi et al., “Cell proliferation and drug resistance in hepatocellular carcinoma are modulated by Rho GTPase signals,” American Journal of Physiology, vol. 290, no. 4, pp. G624–G632, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Taras, J. F. Blanc, A. Rullier et al., “Pravastatin reduces lung metastasis of rat hepatocellular carcinoma via a coordinated decrease of MMP expression and activity,” Journal of Hepatology, vol. 46, no. 1, pp. 69–76, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. W. Kim, J. H. Yoon, J. R. Kim et al., “Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma,” Cancer Chemotherapy and Pharmacology, vol. 64, no. 3, pp. 497–507, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Gao, Z. Song, Y. Chen et al., “Deregulated expression of Notch receptors in human hepatocellular carcinoma,” Digestive and Liver Disease, vol. 40, no. 2, pp. 114–121, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Qi, H. An, Y. Yu et al., “Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis,” Cancer Research, vol. 63, no. 23, pp. 8323–8329, 2003. View at Google Scholar · View at Scopus
  35. LI. Ning, L. Wentworth, H. Chen, and S. M. Weber, “Down-regulation of Notch1 signaling inhibits tumor growth in human hepatocellular carcinoma,” American Journal of Translational Research, vol. 1, no. 4, pp. 358–366, 2009. View at Google Scholar · View at Scopus
  36. L. Jakobsson, K. Bentley, and H. Gerhardt, “VEGFRs and Notch: a dynamic collaboration in vascular patterning,” Biochemical Society Transactions, vol. 37, no. 6, pp. 1233–1236, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. T. R. Carlson, Y. Yan, X. Wu et al., “Endothelial expression of constitutively active Notch4 elicits reversible arteriovenous malformations in adult mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 28, pp. 9884–9889, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. P. A. Murphy, M. T. Y. Lam, X. Wu et al., “Endothelial Notch4 signaling induces hallmarks of brain arteriovenous malformations in mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 31, pp. 10901–10906, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. D. Miniati, E. B. Jelin, J. Ng et al., “Constitutively active endothelial Notch4 causes lung arteriovenous shunts in mice,” American Journal of Physiology, vol. 298, no. 2, pp. L169–L177, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. X. Z. Wu, G. R. Xie, and D. Chen, “Hypoxia and hepatocellular carcinoma: the therapeutic target for hepatocellular carcinoma,” Journal of Gastroenterology and Hepatology, vol. 22, no. 8, pp. 1178–1182, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Taura, S. De Minicis, E. Seki et al., “Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis,” Gastroenterology, vol. 135, no. 5, pp. 1729–1738, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. Xia, R. Chen, Z. Song et al., “Gene expression prowles during activation of cultured rat hepatic stellate cells by tumoral hepatocytes and fetal bovine serum,” Journal of Cancer Research and Clinical Oncology, vol. 136, no. 2, pp. 309–321, 2010. View at Publisher · View at Google Scholar · View at Scopus